HEMANGIOBLASTOMA
Clinical trials for HEMANGIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new HEMANGIOBLASTOMA trials appear
Sign up with your email to follow new studies for HEMANGIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers? drug combo shows promise in early trial
Disease control OngoingThis phase 2 study tests two drugs, sunitinib and temsirolimus, in 137 people with advanced rare tumors that have no cure. The goal is to see if these drugs can shrink tumors or slow their growth. Participants take one of the two drugs, and researchers measure how long the cancer…
Matched conditions: HEMANGIOBLASTOMA
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
VHL tumor growth study aims to predict which lesions need surgery
Knowledge-focused OngoingThis 5-year study follows 250 people with von Hippel-Lindau disease who have brain or spinal cord tumors. Researchers use regular MRI scans and blood tests to see how fast tumors grow and what factors like hormones might affect growth. The goal is to better understand which tumor…
Matched conditions: HEMANGIOBLASTOMA
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC